|
RAP1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.011300E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.482900E-03 |
| Normal-vs-Stage2 |
2.997100E-04 |
| Normal-vs-Stage3 |
1.363780E-03 |
| Normal-vs-Stage4 |
5.61780000000178E-05 |
| Stage1-vs-Stage2 |
8.360500E-02 |
| Stage1-vs-Stage3 |
4.222800E-01 |
| Stage1-vs-Stage4 |
3.705900E-02 |
| Stage2-vs-Stage3 |
3.609000E-01 |
| Stage2-vs-Stage4 |
8.247800E-01 |
| Stage3-vs-Stage4 |
2.328800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.170300E-04 |
| Normal-vs-AfricanAmerican |
1.125700E-02 |
| Normal-vs-Asian |
3.424900E-03 |
| Caucasian-vs-AfricanAmerican |
7.646200E-01 |
| Caucasian-vs-Asian |
9.419600E-01 |
| AfricanAmerican-vs-Asian |
7.850000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.559820E-03 |
| Normal-vs-Female |
5.011000E-04 |
| Male-vs-Female |
8.326400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.189720E-02 |
| Normal-vs-Age(41-60Yrs) |
6.830200E-04 |
| Normal-vs-Age(61-80Yrs) |
2.07519999999572E-05 |
| Normal-vs-Age(81-100Yrs) |
2.005400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.040800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.517800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.914600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.296770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.453800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.191600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.874000E-01 |
| Classical-VS-Follicular |
5.569000E-04 |
| Classical-VS-Other |
7.336600E-01 |
| Classical-VS-Normal |
8.895100E-03 |
| Tall-VS-Follicular |
2.545800E-02 |
| Tall-VS-Other |
9.118600E-01 |
| Tall-VS-Normal |
1.554000E-01 |
| Follicular-VS-Other |
1.735960E-01 |
| Follicular-VS-Normal |
4.63419999996439E-06 |
| Other-VS-Normal |
4.623000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.76874999999743E-05 |
| Normal-vs-N1 |
1.431620E-04 |
| N0-vs-N1 |
5.559000E-01 |
|
|
